Skip to main content

and
  1. Article

    Open Access

    Response to: Letter to Editor Regarding “Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study”

    A. David Burden in Dermatology and Therapy (2024)

  2. Article

    Open Access

    Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study

    We evaluated the anti-interleukin-36 receptor antibody spesolimab in patients with moderate-to-severe palmoplantar pustulosis (PPP).

    A. David Burden, Robert Bissonnette, Alexander A. Navarini in Dermatology and Therapy (2023)

  3. Article

    Open Access

    Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis

    Generalized pustular psoriasis (GPP) is a rare autoinflammatory skin disease characterized by flares of widespread erythema with sterile pustules, and can be relapsing with recurrent flares, or persistent with...

    Akimichi Morita, Siew Eng Choon, Hervé Bachelez in Dermatology and Therapy (2023)

  4. Article

    Open Access

    Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)

    We sought to understand key symptoms of generalized pustular psoriasis (GPP) and to confirm the relevance to patients and content validity of the Psoriasis Symptom Scale (PSS) in GPP.

    A. David Burden, Ulrich Mrowietz, Anne M. Skalicky in Dermatology and Therapy (2022)

  5. Article

    Open Access

    Clinical Disease Measures in Generalized Pustular Psoriasis

    Generalized pustular psoriasis (GPP) is a rare neutrophilic skin condition characterized by episodes of widespread eruption of sterile macroscopic pustules that can be associated with systemic inflammation. Th...

    A. David Burden, Siew Eng Choon in American Journal of Clinical Dermatology (2022)

  6. Article

    Open Access

    The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis register

    Psoriatic arthritis (PsA) presents a unique clinical challenge. Affecting joints, skin, nails, and other organs, it is associated with various comorbidities and has a significant impact on quality of life, soc...

    Gareth T. Jones, Gary J. Macfarlane, Karen Forrest Keenan, Paul McNamee in BMC Rheumatology (2021)

  7. Article

    Open Access

    Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

    Palmoplantar pustulosis (PPP) is a chronic, inflammatory skin disease, with high disease burden, that is often refractory to treatment. There is a high unmet clinical need for the treatment of patients with P...

    Ulrich Mrowietz, A. David Burden, Andreas Pinter, Kristian Reich in Dermatology and Therapy (2021)

  8. Article

    Open Access

    Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne

    Acne vulgaris is a highly heritable common, chronic inflammatory disease of the skin for which five genetic risk loci have so far been identified. Here, we perform a genome-wide association study of 3823 cases...

    Christos Petridis, Alexander A. Navarini, Nick Dand in Nature Communications (2018)

  9. No Access

    Article

    Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

    Richard Trembath and colleagues report a meta-analysis of genome-wide association studies for psoriasis, including 2 cohorts genotyped on the custom Immunochip array, in a total of 10,588 cases and 22,806 cont...

    Lam C Tsoi, Sarah L Spain, Jo Knight, Eva Ellinghaus, Philip E Stuart in Nature Genetics (2012)

  10. No Access

    Article

    Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis

    Psoriasis is an inflammatory skin disorder that is inherited as a multifactorial trait. Genetic analyses have repeatedly identified a primary disease susceptibility locus lying within the major histocompatibil...

    Francesca Capon, Paola Di Meglio, Joanna Szaub, Natalie J. Prescott in Human Genetics (2007)